Clinical Trials Logo

Clinical Trial Summary

To evaluate the treatment outcome of unresectable soft tissue sarcoma using response based treatment


Clinical Trial Description

Response after initial chemotherapy is one of the important prognostic factor in many cancers. In this study, treatment will be tailored according to the treatment responses which are assessed by tumor volume reduction, necrosis rate or residual fludeoxyglucose (FDG) uptake in positron emission tomography (PET) scan. ;


Study Design


Related Conditions & MeSH terms

  • Sarcoma
  • Unresectable Localized Soft Tissue Sarcoma

NCT number NCT02784015
Study type Interventional
Source Samsung Medical Center
Contact Ki Woong Sung, MD, PhD
Phone 82-2-3410-3529
Email kiwoong.sung@samsung.com
Status Recruiting
Phase Phase 2
Start date May 2016
Completion date May 2023